Opinion/decision on a Paediatric investigation plan (PIP): Tecovirimat (monohydrate), decision type: , therapeutic area: , PIP number: P/0540/2022
Treatment of orthopoxvirus disease (smallpox, monkeypox, cowpox, and vaccinia)
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
